In a survey of 451 US healthcare professionals, over 80% supported medical cannabis legalization (especially CBD for epilepsy), but 40-50% reported significant knowledge gaps in cannabinoid pharmacology and clinical applications.
Medical educators, healthcare policy makers, and professional organizations developing cannabis curricula.
80%+ support; 40-50% unfamiliar with pharmacology; pharmacists most knowledgeable
What the researchers found
Over 80% supported medical cannabis use and legalization, especially CBD for epilepsy when prescribed by a provider. However, 40-50% felt unfamiliar with cannabinoid pharmacology and clinical applications. Pharmacists scored highest on knowledge tests; NPs/nurses had most favorable attitudes. State cannabis laws and favorable workplace policies were associated with higher knowledge and more positive attitudes. Only 43% favored recreational legalization.
Why it matters
The gap between support (80%+) and knowledge (40-50% unfamiliar) means healthcare professionals are endorsing treatments they do not fully understand. This has direct implications for patient safety and counseling quality.
The numbers in context
451 respondents; >80% support medical cannabis; 40-50% feel unfamiliar; 43% support recreational; pharmacists: highest knowledge; NPs/nurses: most favorable attitudes; state laws predicted both knowledge and attitudes.
How the study worked
Online survey of 451 US-based neurologists, nurse practitioners/nurses, and pharmacists (August-September 2018), using constructed knowledge tests, perceived knowledge scales, and attitudes scales with OLS regression.
What this study cannot tell us
Online convenience sample (response bias likely); 451 is moderate for 3 professions; self-reported knowledge may differ from actual competency; 2018 data predates further legalization; does not assess actual prescribing/recommending behavior.
How to read the evidence
Moderate: reasonable sample across 3 professions, but convenience sampling limits generalizability.
When this study was published
Published 2020.
The bigger picture
Professional education has not kept pace with cannabis policy changes. Pharmacists, who scored highest on knowledge, are underutilized in cannabis counseling. Medical schools and nursing programs need formal cannabinoid education.
Questions still open
- Would formal cannabinoid education change prescribing patterns? Should pharmacists take a larger role in medical cannabis counseling?
Common questions
Do doctors support medical cannabis?
Which healthcare professionals know most about cannabis?
Read the original research
Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
Epilepsy & behavior : E&B, 109, 107102
Citation
Szaflarski, Magdalena; McGoldrick, Patricia; Currens, Lauryn; Blodgett, Dustin; Land, Hunter; Szaflarski, Jerzy P; Segal, Eric. (2020). Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.. Epilepsy & behavior : E&B, 109, 107102. https://doi.org/10.1016/j.yebeh.2020.107102
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk